This Bio-Pharma stock looks ready for a huge move! | ROIV Stock Analysis | Ep.66

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. I will be doing a full stock analysis, chart review, and a dive into their earnings reports.
📈📈📈📈📈📈📈📈📈📈📈📈
Not Sponsored, but consider this:
Join Robinhood With this link and receive $5-$200 FREE (I also get $5 free):
https://join.robinhood.com/andrewf-0ddf29
📈📈📈📈📈📈📈📈📈📈📈📈
I use this channel to encourage myself to learn more and also keep myself accountable with my own money. Hope you get something out of watching this! In my videos I go over the latest trending stocks, unknown stocks, stock picks, and stock market tips!
📈📈📈📈📈📈📈📈📈📈📈📈
DISCLAIMER: I AM NOT A TRAINED FINANCIAL ADVISOR PLEASE DO YOUR OWN INVESTMENT RESEARCH THIS IS FOR ENTERTAINMENT PURPOSES ONLY. I DO NOT RECCOMEND PURCHASING OR INVESTING IN ANY STOCKS OR SECURITIES MENTIONED IN ANY OF MY VIDEOS !!!!!!!!!!!!!!!!
📈📈📈📈📈📈📈📈📈📈📈📈
#stockanalysis #trendingstocks #technicalanalysis

Видео This Bio-Pharma stock looks ready for a huge move! | ROIV Stock Analysis | Ep.66 канала Skook Buffett